GENE ONLINE|News &
Opinion
Blog

neoantigen
New IO Targets and Resistance Mechanisms of Immune Checkpoint-Based Therapies
2021-06-10
Researchers Design Novel Bispecific Antibodies to Nab “Hard-to-Target” Cancer Drivers
2021-03-09
LATEST
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Takeda Signs New Deal with PeptiDream Spending Billions to Develop Neuromuscular Disease Drugs
2021-07-30
The Evolution of Cytokine Therapies for a Broad Spectrum of Disorders
2021-07-30
PerkinElmer Makes its Biggest Buy Yet Forking Out $5.25 Billion for Latest Acquisition
2021-07-30
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Scroll to Top

Subscribe To Our News

Keep yourself updated at all times!